Clin2
NCT06542237Possibly a fitRecruiting

Study of a new male birth control pill for healthy men

Male Contraception

Part of Cancer, Genetic & congenital, Hormones & metabolism clinical trials.

This trial tests an experimental birth control pill (YCT-529) taken daily. It aims to see if the drug can safely and effectively prevent pregnancy in healthy men who do not plan to have children in the future.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
88 people
Ages
28 years to 70 years
Study type
Interventional

Who can take part

  • Healthy man aged 28 to 70
  • Decided not to father children (or waiting for a vasectomy)
  • Body mass index between 18 and 35
  • Normal sperm count and quality
  • Not using hormone therapy or certain hair loss drugs in the past 90 days

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07393334Recruiting· Phase 2
Male birth control pill trial

This trial tests a new non-hormonal male contraceptive pill called NLS-133. It is taken just before sex and could help give men more control over family planning.

Seattle, Washington
NCT07811063Not yet recruiting· Phase 1
Testing a new tablet in healthy adults

This study tests a single dose of a new tablet medication (called TRTL-729) in healthy adults. It helps researchers learn how the drug is absorbed and tolerated, which is a first step in developing a treatment.

Auckland
NCT07361120Recruiting· Phase 2
Plan a vasectomy device study for long-term birth control

This study tests a new device for vasectomy. It's for men who want a long-term birth control option and are in good health, between 25 and 65 years old, with a normal body weight and sperm count.

Maribyrnong, Victoria
NCT07714616Not yet recruiting· Phase 3
New birth control pill for women

This trial tests a new birth control pill with a lower dose of estrogen and a different type of progestin. It aims to see how well it prevents pregnancy and if it's safe for women to use.

NCT07285967Not yet recruiting· Phase 1
First-in-human study of YR011 tablet in healthy volunteers

This study tests a new oral medication called YR011 for the first time in people. It aims to find a safe dose and see how the body handles it, which may help treat future conditions.

NCT07674940Recruiting· Phase 1
Study of a new drug at different doses in healthy people

This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.

Miramar, Florida

Hear when a new Male Contraception trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.